ArticleCancer management and research2020

Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma.

Yuan Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.